We are live on ! Find out more
AB

Amalgamated Bank Portfolio holdings

AUM $14.5B
1-Year Est. Return 44.3%
This Fund
S&P 500
This Quarter Est. Return
+11.8%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$2.3B
AUM Growth
+$139M
Cap. Flow
-$51.8M
Cap. Flow %
-2.25%
Top 10 Hldgs %
21.5%
Holding
1,536
New
54
Increased
235
Reduced
1,203
Closed
38

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$9.14M
2
IWV icon
iShares Russell 3000 ETF
IWV
+$8.45M
3
AAPL icon
Apple
AAPL
+$5.08M
4
MSFT icon
Microsoft
MSFT
+$3.17M
5
AMZN icon
Amazon
AMZN
+$2.34M

Sector Composition

Rank Sector Weight
1 Technology 24.58%
2 Healthcare 14.72%
3 Consumer Discretionary 12.26%
4 Financials 11.11%
5 Industrials 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NLY icon
901
Annaly Capital Management
NLY
$17.1B
$449K 0.02%
15,777
-337
-2% -$9.76K
PTCT icon
902
PTC Therapeutics
PTCT
$5.67B
$449K 0.02%
9,609
-278
-3% -$13.7K
IART icon
903
Integra LifeSciences
IART
$1.28B
$447K 0.02%
9,469
-39
-0.4% -$1.85K
SPSC icon
904
SPS Commerce
SPSC
$2.69B
$447K 0.02%
5,745
-189
-3% -$14.4K
TPTX
905
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$447K 0.02%
5,115
+800
+19% +$55.7K
AMN icon
906
AMN Healthcare
AMN
$1.3B
$446K 0.02%
7,634
-242
-3% -$12.7K
FATE icon
907
Fate Therapeutics
FATE
$288M
$445K 0.02%
11,141
+1,116
+11% +$39K
BBBY
908
Bed Bath & Beyond
BBBY
$487M
$443K 0.02%
+6,708
New +$457K
CXO
909
DELISTED
CONCHO RESOURCES INC.
CXO
$443K 0.02%
10,040
-177
-2% -$8.83K
EYE icon
910
National Vision
EYE
$1.76B
$442K 0.02%
11,552
-300
-3% -$10.4K
PRNB
911
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$442K 0.02%
4,397
-124
-3% -$11K
HPP
912
Hudson Pacific Properties
HPP
$758M
$438K 0.02%
2,852
-14
-0.5% -$2.31K
RL icon
913
Ralph Lauren
RL
$22.8B
$438K 0.02%
6,439
-129
-2% -$9.19K
VIAV icon
914
Viavi Solutions
VIAV
$9.17B
$438K 0.02%
37,358
-1,228
-3% -$15.9K
SYNA icon
915
Synaptics
SYNA
$4.29B
$437K 0.02%
5,437
-168
-3% -$13.3K
VTRS icon
916
Viatris
VTRS
$20.4B
$434K 0.02%
29,282
-606
-2% -$9.68K
TGTX icon
917
TG Therapeutics
TGTX
$8.06B
$432K 0.02%
16,143
+1,722
+12% +$39.6K
CACC icon
918
Credit Acceptance
CACC
$5.95B
$431K 0.02%
1,274
-37
-3% -$15.6K
OXY icon
919
Occidental Petroleum
OXY
$56.3B
$431K 0.02%
43,068
-479
-1% -$6.75K
JBGS
920
JBG SMITH
JBGS
$821M
$430K 0.02%
16,098
-98
-0.6% -$2.75K
HST icon
921
Host Hotels & Resorts
HST
$17.2B
$429K 0.02%
39,715
-848
-2% -$9.37K
LCII icon
922
LCI Industries
LCII
$2.48B
$429K 0.02%
4,032
-128
-3% -$14.9K
GAP
923
The Gap Inc
GAP
$7.29B
$429K 0.02%
25,186
-253
-1% -$3.77K
ALRM icon
924
Alarm.com
ALRM
$2.69B
$427K 0.02%
7,730
+111
+1% +$6.86K
FELE icon
925
Franklin Electric
FELE
$4.59B
$426K 0.02%
7,242
-220
-3% -$12.5K

Similar funds

Amalgamated Bank's Q3 2020 Portfolio in Review

As of Q3 2020, Amalgamated Bank held 1,536 positions worth $2.3B, up 6.4% from $2.16B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Amalgamated Bank's Q3 2020 filing shows 54 new, 235 increased, 1,203 reduced and 38 closed positions. Its largest new stake was Medtronic: 76,254 shares worth $7.92M. The largest sale was Accenture, an estimated $9.14M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Amalgamated Bank's largest Q3 2020 buy was Medtronic: 76,254 shares worth $7.92M.
  • Amalgamated Bank added most to Match Group in Q3 2020, an estimated $912K increase.
  • Amalgamated Bank's biggest Q3 2020 reduction was iShares Russell 3000 ETF, cutting an estimated $8.45M.
  • Amalgamated Bank fully exited Accenture in Q3 2020, selling an estimated $9.14M.
  • Amalgamated Bank's ten largest holdings make up 22% of its $2.3B portfolio in Q3 2020.
  • Amalgamated Bank opened 54 new positions and closed 38 in Q3 2020.
  • Amalgamated Bank's portfolio value rose 6.4% quarter-over-quarter to $2.3B.

Based on Amalgamated Bank's 13F filing for Q3 2020, filed 30 Oct 2020.